NCT00378521View on ClinicalTrials.gov

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Autoimmune Disease
Interventions
DRUG

MQX-503

Trial Locations (1)

98055

Rainier Clinical Research, Renton

Sponsors
All Listed Sponsors
lead

MediQuest Therapeutics

INDUSTRY